Applications
Opiates on Synergi Max-RP
14253
Separation Mode: Reversed Phase
Reversed Phase
Max-RP
HPLC
Analgesics, Opioid
Clinical
Pharmaceutical
Therapeutic / Clinical

Applications

Opiates on Synergi Max-RP

Analytes

1
2
3
4
Compound Name
Morphine
CID
5288826
Molecular Formula
C17H19NO3
Molecular Weight
285
No. Hydrogen Bond Acceptors
4
No. Hydrogen Bond Donors
2

Conditions

LC Conditions (App ID: 14253)
Column:Synergi 4 µm Max-RP 80 Å, LC Column 150 x 4.6 mm, Ea
Brand Name:Synergi
Part No:00F-4337-E0
Elution Type:Gradient
Mobile Phase:A: 20mM Potassium dihydrogen phosphate
B: Acetonitrile
Gradient Profile:
Step No.Time(min)%A%B
10955
2156535
Flow Rate:1.5 mL/min
Temperature:22°C
Detection:UV-Vis Abs.-Variable Wave.(UV) nm @ 22°C

Order Items Used in This Application

Similar Applications
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm F5 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm F5 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm F5 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase
Kinetex 2.6 µm F5 100 Å, LC Column 50 x 4.6 mm, Ea
Reversed Phase